AVUTOMETINIB

Clinical trials for AVUTOMETINIB explained in plain language.

Never miss a new study

Get alerted when new AVUTOMETINIB trials appear

Sign up with your email to follow new studies for AVUTOMETINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New Triple-Drug attack on tough endometrial cancer begins testing

Disease control Not yet recruiting

This early-phase study aims to find a safe and effective dose of a three-drug combination (avutometinib, defactinib, and everolimus) for people with recurrent endometrial cancer that has specific genetic changes in the RAS pathway. It will enroll about 31 participants who have al…

Matched conditions: AVUTOMETINIB

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 23, 2026 15:18 UTC

AVUTOMETINIB

Get alerted when new AVUTOMETINIB trials appear

New Triple-Drug attack on tough endometrial cancer begins testing